Key Financial Data Of Reporting Company

Chiome Bioscience Inc. - Filing #7593791

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
2022-01-01 to
2022-06-30
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-06-30
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
278,211,000 JPY
712,932,000 JPY
384,932,000 JPY
Ordinary profit (loss)
-768,686,000 JPY
-1,329,312,000 JPY
-409,402,000 JPY
Profit (loss)
-771,005,000 JPY
-1,479,895,000 JPY
-408,737,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
1,695,249,000 JPY
1,515,929,000 JPY
1,471,439,000 JPY
Total number of issued shares
43,057,600 xbrli:shares
40,781,500 xbrli:shares
40,291,500 xbrli:shares
Net assets
1,476,135,000 JPY
1,893,049,000 JPY
2,858,871,000 JPY
Total assets
1,920,212,000 JPY
2,339,439,000 JPY
3,328,800,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-6.53
-18.17
-36.74
-10.16
-6.16
Diluted earnings per share
Equity-to-asset ratio
0.753 xbrli:pure
0.794 xbrli:pure
0.853 xbrli:pure
Net cash provided by (used in) operating activities
-660,225,000 JPY
-1,131,291,000 JPY
-560,856,000 JPY
Net cash provided by (used in) investing activities
JPY
-35,384,000 JPY
JPY
Net cash provided by (used in) financing activities
341,172,000 JPY
271,345,000 JPY
176,141,000 JPY
Cash and cash equivalents
1,471,935,000 JPY
1,790,988,000 JPY
2,301,603,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.